UNLABELLED: Uncoupling protein 3 (UCP3) is a member of the mitochondrial solute carrier superfamily that is enriched in skeletal muscle and controls mitochondrial reactive oxygen species (ROS) production, but the mechanisms underlying this function are unclear. AIMS: The goal of this work focused on the identification of mechanisms underlying UCP3 functions. RESULTS: Here we report that the N-terminal, intermembrane space (IMS)-localized hydrophilic domain of mouse UCP3 interacts with the N-terminal mitochondrial targeting signal of thioredoxin 2 (Trx2), a mitochondrial thiol reductase. Cellular immunoprecipitation and in vitro pull-down assays show that the UCP3-Trx2 complex forms directly, and that the Trx2 N-terminus is both necessary and sufficient to confer UCP3 binding. Mutation studies show that neither a catalytically inactivated Trx2 mutant, nor a mutant Trx2 bearing the N-terminal targeting sequence of cytochrome c oxidase (COXMTS-Trx2) bind UCP3. Biochemical analyses using permeabilized mitochondria, and live cell experiments using bimolecular fluorescence complementation show that the UCP3-Trx2 complex forms specifically in the IMS. Finally, studies in C2C12 myocytes stably overexpressing UCP3 (2.5-fold) and subjected to Trx2 knockdown show that Trx2 is required for the UCP3-dependent mitigation of complex III-driven mitochondrial ROS generation. UCP3 expression was increased in mice fed a high fat diet, leading to increased localization of Trx2 to the IMS. UCP3 overexpression also increased expression of the glucose transporter GLUT4 in a Trx2-dependent fashion. INNOVATION: This is the first report of a mitochondrial protein-protein interaction with UCP3 and the first demonstration that UCP3 binds directly, and in cells and tissues with mitochondrial thioredoxin 2. CONCLUSION: These studies identify a novel UCP3-Trx2 complex, a novel submitochondrial localization of Trx2, and a mechanism underlying UCP3-regulated mitochondrial ROS production.
UNLABELLED: Uncoupling protein 3 (UCP3) is a member of the mitochondrial solute carrier superfamily that is enriched in skeletal muscle and controls mitochondrial reactive oxygen species (ROS) production, but the mechanisms underlying this function are unclear. AIMS: The goal of this work focused on the identification of mechanisms underlying UCP3 functions. RESULTS: Here we report that the N-terminal, intermembrane space (IMS)-localized hydrophilic domain of mouse UCP3 interacts with the N-terminal mitochondrial targeting signal of thioredoxin 2 (Trx2), a mitochondrial thiol reductase. Cellular immunoprecipitation and in vitro pull-down assays show that the UCP3-Trx2 complex forms directly, and that the Trx2 N-terminus is both necessary and sufficient to confer UCP3 binding. Mutation studies show that neither a catalytically inactivated Trx2 mutant, nor a mutant Trx2 bearing the N-terminal targeting sequence of cytochrome c oxidase (COXMTS-Trx2) bind UCP3. Biochemical analyses using permeabilized mitochondria, and live cell experiments using bimolecular fluorescence complementation show that the UCP3-Trx2 complex forms specifically in the IMS. Finally, studies in C2C12 myocytes stably overexpressing UCP3 (2.5-fold) and subjected to Trx2 knockdown show that Trx2 is required for the UCP3-dependent mitigation of complex III-driven mitochondrial ROS generation. UCP3 expression was increased in mice fed a high fat diet, leading to increased localization of Trx2 to the IMS. UCP3 overexpression also increased expression of the glucose transporter GLUT4 in a Trx2-dependent fashion. INNOVATION: This is the first report of a mitochondrial protein-protein interaction with UCP3 and the first demonstration that UCP3 binds directly, and in cells and tissues with mitochondrial thioredoxin 2. CONCLUSION: These studies identify a novel UCP3-Trx2 complex, a novel submitochondrial localization of Trx2, and a mechanism underlying UCP3-regulated mitochondrial ROS production.
Authors: Cheol Soo Choi; Jonathan J Fillmore; Jason K Kim; Zhen-Xiang Liu; Sheene Kim; Emily F Collier; Ameya Kulkarni; Alberto Distefano; Yu-Jin Hwang; Mario Kahn; Yan Chen; Chunli Yu; Irene K Moore; Richard M Reznick; Takamasa Higashimori; Gerald I Shulman Journal: J Clin Invest Date: 2007-07 Impact factor: 14.808
Authors: Rong Zhang; Rafia Al-Lamki; Lanfang Bai; Jeffrey W Streb; Joseph M Miano; John Bradley; Wang Min Journal: Circ Res Date: 2004-04-29 Impact factor: 17.367
Authors: Brian A Stanley; Vidhya Sivakumaran; Sa Shi; Iain McDonald; David Lloyd; Walter H Watson; Miguel A Aon; Nazareno Paolocci Journal: J Biol Chem Date: 2011-08-05 Impact factor: 5.157
Authors: Lia S Nakao; Robert A Everley; Stefano M Marino; Sze M Lo; Luiz E de Souza; Steven P Gygi; Vadim N Gladyshev Journal: J Biol Chem Date: 2015-01-05 Impact factor: 5.157
Authors: Sihem Boudina; Sandra Sena; Crystal Sloan; Ali Tebbi; Yong Hwan Han; Brian T O'Neill; Robert C Cooksey; Deborah Jones; William L Holland; Donald A McClain; E Dale Abel Journal: Endocrinology Date: 2012-04-17 Impact factor: 4.736
Authors: Sara M Nowinski; Ashley Solmonson; Joyce E Rundhaug; Okkyung Rho; Jiyoon Cho; Cory U Lago; Christopher L Riley; Sunhee Lee; Shohei Kohno; Christine K Dao; Takeshi Nikawa; Shawn B Bratton; Casey W Wright; Susan M Fischer; John DiGiovanni; Edward M Mills Journal: Nat Commun Date: 2015-08-27 Impact factor: 14.919